In this study, the presence of core fucosylation modifications on the VEGFR-2 by immunoprecipitation was demonstrated, and the results show that reducing the level of core fucosylation affected its downstream AKT pathway, providing a new idea for the progress and treatment of pulmonary hypertension by influencing glycosylation levels. The gene discussed is AKT1; the disease is pulmonary hypertension.